101 related articles for article (PubMed ID: 7649231)
1. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions.
Thomas LB; Gates DJ; Richfield EK; O'Brien TF; Schweitzer JB; Steindler DA
Exp Neurol; 1995 Jun; 133(2):265-72. PubMed ID: 7649231
[TBL] [Abstract][Full Text] [Related]
2. Evidence for apoptotic cell death in Alzheimer's disease.
Smale G; Nichols NR; Brady DR; Finch CE; Horton WE
Exp Neurol; 1995 Jun; 133(2):225-30. PubMed ID: 7544290
[TBL] [Abstract][Full Text] [Related]
3. A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain.
Curtis MA; Faull RL; Glass M
J Chem Neuroanat; 2006 Apr; 31(3):210-5. PubMed ID: 16533591
[TBL] [Abstract][Full Text] [Related]
4. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
5. A cautionary note on the use of the TUNEL stain to determine apoptosis.
Charriaut-Marlangue C; Ben-Ari Y
Neuroreport; 1995 Dec; 7(1):61-4. PubMed ID: 8742417
[TBL] [Abstract][Full Text] [Related]
6. Global changes to the ubiquitin system in Huntington's disease.
Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
[TBL] [Abstract][Full Text] [Related]
7. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
8. Pre-embedding immunogold labeling of TUNEL stain enables evaluation of DNA strand breaks and ultrastructural alterations in individual cells of neuronal tissue.
Barth M; Oulmi Y; Ehrenreich H; Schilling L
Acta Neuropathol; 2002 Dec; 104(6):621-36. PubMed ID: 12410384
[TBL] [Abstract][Full Text] [Related]
9. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
10. Age does not influence DNA fragmentation in the hippocampus after fatal traumatic brain injury in young and aged humans compared with controls.
Fowler J; MacKinnon MA; Raghupathi R; Saatman KE; McIntosh TK; Graham DI
Clin Neuropathol; 2002; 21(4):156-62. PubMed ID: 12143927
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic advances in neurodegenerative disorders.
Aguilera AJ
Clin Lab Med; 1995 Dec; 15(4):915-26. PubMed ID: 8838230
[TBL] [Abstract][Full Text] [Related]
12. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
13. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain.
Curtis MA; Penney EB; Pearson J; Dragunow M; Connor B; Faull RL
Neuroscience; 2005; 132(3):777-88. PubMed ID: 15837138
[TBL] [Abstract][Full Text] [Related]
14. Differences in cell death between high and low energy brain injury in adult rats.
Lindh C; Wennersten A; Arnberg F; Holmin S; Mathiesen T
Acta Neurochir (Wien); 2008 Dec; 150(12):1269-75;discussion 1275. PubMed ID: 19015811
[TBL] [Abstract][Full Text] [Related]
15. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease.
Furtado S; Suchowersky O; Rewcastle B; Graham L; Klimek ML; Garber A
Ann Neurol; 1996 Jan; 39(1):132-6. PubMed ID: 8572659
[TBL] [Abstract][Full Text] [Related]
16. Increase in bax expression and apoptosis are associated in Huntington's disease progression.
Teles AV; Rosenstock TR; Okuno CS; Lopes GS; Bertoncini CR; Smaili SS
Neurosci Lett; 2008 Jun; 438(1):59-63. PubMed ID: 18468793
[TBL] [Abstract][Full Text] [Related]
17. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat.
Newcomb JK; Zhao X; Pike BR; Hayes RL
Exp Neurol; 1999 Jul; 158(1):76-88. PubMed ID: 10448419
[TBL] [Abstract][Full Text] [Related]
18. [Calcium, neuronal death and neurological disease].
Jiménez-Jiménez FJ; García-Ruiz PJ; de Bustos F
Rev Neurol; 1996 Oct; 24(134):1199-209. PubMed ID: 8983715
[TBL] [Abstract][Full Text] [Related]
19. Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model.
Li W; Dai S; An J; Xiong R; Li P; Chen X; Zhao Y; Liu P; Wang H; Zhu P; Chen J; Zhou Y
Exp Neurol; 2009 Jan; 215(1):69-76. PubMed ID: 18938161
[TBL] [Abstract][Full Text] [Related]
20. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease.
Bando Y; Onuki R; Katayama T; Manabe T; Kudo T; Taira K; Tohyama M
Neurochem Int; 2005 Jan; 46(1):11-8. PubMed ID: 15567511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
